A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

05 Feb 20264 min read0 viewsINTERVENTIONAL Trial

GIST (Key Takeaways)

RECRUITING · INTERVENTIONAL · TREATMENT study · Peripheral T Cell Lymphoma · Phase 2 · Enrollment 40 · Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Editorial

ClinicalTrials.gov published a clinical update in Infectious Disease on 05 Feb 2026. The item focuses on A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma. Open the detail page to review the full original feed content.